688131 皓元医药
2024/09 - 九个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)5.4995.2789.35016.25327.693
总资产报酬率 ROA (%)3.2303.2726.47411.78418.356
投入资产回报率 ROIC (%)3.6713.7857.55513.86322.771

边际利润分析
销售毛利率 (%)47.58145.16851.44454.11856.674
营业利润率 (%)9.7446.82614.47421.64123.412
息税前利润/营业总收入 (%)11.2728.51314.57722.26124.787
净利润/营业总收入 (%)8.6956.71814.10519.66220.223

收益指标分析
经营活动净收益/利润总额(%)149.358161.741107.449109.025113.942
价值变动净收益/利润总额(%)-3.190-3.7238.085-0.0570.978
营业外收支净额/利润总额(%)0.046-0.1060.995-0.111-0.051

偿债能力分析
流动比率 (X)1.9641.8802.2174.9442.160
速动比率 (X)1.0130.8961.1093.8491.384
资产负债率 (%)41.88739.73935.18322.98638.401
带息债务/全部投入资本 (%)23.42624.23215.3670.69518.809
股东权益/带息债务 (%)279.018282.011492.78912,717.344405.343
股东权益/负债合计 (%)137.843150.611183.280332.471160.412
利息保障倍数 (X)7.3995.025-342.76634.56917.871

营运能力分析
应收账款周转天数 (天)85.03575.32063.74341.66837.542
存货周转天数 (天)365.395359.057344.748235.069247.717